What is the amoxicillin and clavulanic acid injection?

Amoxicillin and clavulanic acid injection, marketed as Numclav-1.2, is a widely used antibiotic combination designed to combat a variety of bacterial infections. It combines a penicillin-class antibiotic with a beta-lactamase inhibitor to enhance antibacterial effectiveness.

How It Works

Amoxycillin works by inhibiting bacterial cell wall synthesis, leading to the destruction of bacteria. Clavulanic acid protects amoxycillin from degradation by beta-lactamase enzymes produced by resistant bacteria, thereby extending its spectrum of activity.

Indications

Numclav-1.2 Injection is indicated for respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, and intra-abdominal infections. It is especially useful in treating infections caused by resistant bacterial strains.

Amoxicillin and clavulanic acid injection Benefits

Broad-spectrum antibacterial coverage
Effective against beta-lactamase, producing bacteria
Rapid action in severe infections
Suitable for hospital and critical care use
Enhances treatment success rates

This injection is administered intravenously under medical supervision. Dosage depends on the severity of infection and patient condition. Patients with penicillin allergies or liver disorders should use it cautiously. Monitoring is recommended during prolonged therapy.

Conclusion
Numclav-1.2 Injection is a reliable and effective antibiotic option for managing serious infections, ensuring faster recovery and improved patient outcomes.